Michael F. Clarke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michael F. Clarke has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Michael W. Becker
University of Rochester Medical Center
1 shared publication Muhammad Al-Hajj
University of Michigan Medical School, CCGC Room 4410, 1500 E Medical Center Drive, Ann Arbor 48109-0936, USA
1 shared publicationShun-Hsin Liang
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109-0936, USA
1 shared publicationShun‐Hsin Liang
Department of Biology, The Pennsylvania State University, University Park, USA
1 shared publication
Latest Publications
- 5 November 2005
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 56 (S1) , 64-68
A self-renewal assay for cancer stem cells
Cancers of epithelial origin are responsible for the majority of cancer-related deaths in the USA. Unfortunately, although chemotherapy and/or radiation therapy can sometimes shrink tumors, metastatic cancers of epithelial origin are essentially incurable. It is clear that new approaches are needed to treat these diseases. Although cancer cell lines provide invaluable information, their biological properties often differ in crucial ways from de novo cancer cells. Our laboratory has developed a novel mouse model that reliably permits individual cancer cells isolated directly from patients’ tumors to be assayed. This will allow the characterization of crucial signaling pathways involved in processes such as self-renewal that are critical for tumor formation by the cancer cells within de novo tumors. These tools should lead to new insights into the cellular and molecular mechanisms that drive human breast cancer growth and invasion.
- 5 November 2005
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 56 (S1) , 64-68
A self-renewal assay for cancer stem cells
Cancers of epithelial origin are responsible for the majority of cancer-related deaths in the USA. Unfortunately, although chemotherapy and/or radiation therapy can sometimes shrink tumors, metastatic cancers of epithelial origin are essentially incurable. It is clear that new approaches are needed to treat these diseases. Although cancer cell lines provide invaluable information, their biological properties often differ in crucial ways from de novo cancer cells. Our laboratory has developed a novel mouse model that reliably permits individual cancer cells isolated directly from patients’ tumors to be assayed. This will allow the characterization of crucial signaling pathways involved in processes such as self-renewal that are critical for tumor formation by the cancer cells within de novo tumors. These tools should lead to new insights into the cellular and molecular mechanisms that drive human breast cancer growth and invasion.
- 1 June 2005
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1044 (1) , 90-93
Epigenetic Regulation of Normal and Cancer Stem Cells
Abstract: In many tissues, a cellular hierarchy exists in which a small population of stem cells is responsible for the production of the mature cells of the organ. The stem cells maintain themselves through a process known as self‐renewal. Similarly, tumors contain a minority population of cancer stem cells that maintain the tumor. Some factors that regulate this process of self‐renewal are conserved from fruit fly to humans. Disruption of the regulation of self‐renewal results in cancer. Thus understanding the mechanisms that regulate stem cell generation has implications for normal development and disease.
- 1 June 2005
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1044 (1) , 90-93
Epigenetic Regulation of Normal and Cancer Stem Cells
Abstract: In many tissues, a cellular hierarchy exists in which a small population of stem cells is responsible for the production of the mature cells of the organ. The stem cells maintain themselves through a process known as self‐renewal. Similarly, tumors contain a minority population of cancer stem cells that maintain the tumor. Some factors that regulate this process of self‐renewal are conserved from fruit fly to humans. Disruption of the regulation of self‐renewal results in cancer. Thus understanding the mechanisms that regulate stem cell generation has implications for normal development and disease.
- Open Access
- 1 February 2005
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 11 (2) , 14-16
Self-renewal and solid-tumor stem cells
- 1 February 2005
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 11 (2) , 14-16
Open AccessSelf-renewal and solid-tumor stem cells
- 17 November 2004
- Published by Springer Nature in Nature
- Vol. 432 (7015) , 281-282
At the root of brain cancer
- 17 November 2004
- Published by Springer Nature in Nature
- Vol. 432 (7015) , 281-282
At the root of brain cancer
- 20 September 2004
- Published by Springer Nature in Oncogene
- Vol. 23 (43) , 7274-7282
Self-renewal and solid tumor stem cells
Solid tumors arise in organs that contain stem cell populations. The tumors in these tissues consist of heterogeneous populations of cancer cells that differ markedly in their ability to proliferate and form new tumors. In both breast cancers and central nervous system tumors, cancer cells differ in their ability to form tumors. While the majority of the cancer cells have a limited ability to divide, a population of cancer stem cells that has the exclusive ability to extensively proliferate and form new tumors can be identified based on marker expression. Growing evidence suggests that pathways that regulate the self-renewal of normal stem cells are deregulated in cancer stem cells resulting in the continuous expansion of self-renewing cancer cells and tumor formation. This suggests that agents that target the defective self-renewal pathways in cancer cells might lead to improved outcomes in the treatment of these diseases.
- 20 September 2004
- Published by Springer Nature in Oncogene
- Vol. 23 (43) , 7274-7282
Self-renewal and solid tumor stem cells
Solid tumors arise in organs that contain stem cell populations. The tumors in these tissues consist of heterogeneous populations of cancer cells that differ markedly in their ability to proliferate and form new tumors. In both breast cancers and central nervous system tumors, cancer cells differ in their ability to form tumors. While the majority of the cancer cells have a limited ability to divide, a population of cancer stem cells that has the exclusive ability to extensively proliferate and form new tumors can be identified based on marker expression. Growing evidence suggests that pathways that regulate the self-renewal of normal stem cells are deregulated in cancer stem cells resulting in the continuous expansion of self-renewing cancer cells and tumor formation. This suggests that agents that target the defective self-renewal pathways in cancer cells might lead to improved outcomes in the treatment of these diseases.
- Open Access
- 15 May 2001
- Published by Wiley in European Journal of Biochemistry
- Vol. 268 (10) , 2779-2783
Regulation of p53 localization
Despite intensive study of p53, the regulation of p53 cellular localization is still poorly understood. This is an overview of the elements and molecules involved in p53 nucleocytoplasmic transportation. These include the nuclear import and export signals of p53, inhibition of p53 nuclear import and export by oligomerization, MDM2‐mediated p53 nuclear export, and possible roles of p53 phosphorylation in regulating p53 cellular localization. Finally, questions regarding p53 cellular trafficking will also be discussed.
- 15 May 2001
- Published by Wiley in European Journal of Biochemistry
- Vol. 268 (10) , 2779-2783
Open AccessRegulation of p53 localization
Despite intensive study of p53, the regulation of p53 cellular localization is still poorly understood. This is an overview of the elements and molecules involved in p53 nucleocytoplasmic transportation. These include the nuclear import and export signals of p53, inhibition of p53 nuclear import and export by oligomerization, MDM2‐mediated p53 nuclear export, and possible roles of p53 phosphorylation in regulating p53 cellular localization. Finally, questions regarding p53 cellular trafficking will also be discussed.
- Open Access
- 1 November 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (46) , 32699-32703
A Bipartite Nuclear Localization Signal Is Required for p53 Nuclear Import Regulated by a Carboxyl-terminal Domain
- 1 November 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (46) , 32699-32703
Open AccessA Bipartite Nuclear Localization Signal Is Required for p53 Nuclear Import Regulated by a Carboxyl-terminal Domain